Evolving treatment modalities for immune thrombocytopenia in adults

Evolving treatment modalities for immune thrombocytopenia in adults

The management of patients with relapsed or refractory immune thrombocytopenia (ITP) remains challenging for hematologists. While there are a multitude of drugs available, it is largely an individualized management based on patient preferences, side effects, previous treatment received, and response...

Full description

Bibliographic Details
Main Authors: Sushmita Khadka, Vineela Kasireddy, Pravash Kumar Dhakal, Chandrakala Dadiboyina
Format: Article
Language:English
Published: Greater Baltimore Medical Center 2021-01-01
Series:Journal of Community Hospital Internal Medicine Perspectives
Subjects:
immune thrombocytopenia
refractory thrombocytopenia
novel agents for thrombocytopenia
Online Access:http://dx.doi.org/10.1080/20009666.2020.1843237

Internet

http://dx.doi.org/10.1080/20009666.2020.1843237

Similar Items